Emergence of secondary acute lymphoblastic leukemia of Burkitt type after treatment of rhabdomyosarcoma
Takashi Miyagi MD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this authorCorresponding Author
Akitoshi Nagasaki MD, PhD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, 207, Uehara, Nakagami-Nishihara, Okinawa 903-0215, Japan.Search for more papers by this authorTetsuro Nakazato MD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this authorNobuyuki Hyakuna MD, PhD
Department of Pediatrics, Faculty of Medicine, University of The Ryukys, Okinawa, Japan
Search for more papers by this authorNobuyuki Takasu MD, PhD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this authorMasato Masuda MD, PhD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this authorTakashi Miyagi MD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this authorCorresponding Author
Akitoshi Nagasaki MD, PhD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, 207, Uehara, Nakagami-Nishihara, Okinawa 903-0215, Japan.Search for more papers by this authorTetsuro Nakazato MD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this authorNobuyuki Hyakuna MD, PhD
Department of Pediatrics, Faculty of Medicine, University of The Ryukys, Okinawa, Japan
Search for more papers by this authorNobuyuki Takasu MD, PhD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this authorMasato Masuda MD, PhD
Second Department of Internal Medicine, Faculty of Medicine, University of The Ryukyus, Okinawa, Japan
Search for more papers by this author
REFERENCES
- 1 Pagano L, Pulsoni A, Mele L, et al. Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy. Leuk Lymphoma 2000; 39: 465–475.
- 2 Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in child: An update from the late effects study group. J Clin Oncol 1985; 3: 532–538.
- 3 Kaldor J. Second cancer following chemotherapy and radiotherapy. An epidemiological perspective. Acta Oncol 1990; 29: 647–655.
- 4 Geetha N, SreedeviAmma N, Kusumakumary P, et al. Acute lymphoblastic leukemia occurring as a second malignancy: Report a case and review of literature. Pediatr Hematol Oncol 1999; 16: 267–270.
- 5
Scaradavou A,
Heller G,
Sklar CA.
Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
Cancer
1995;
76:
1860–1867.
10.1002/1097-0142(19951115)76:10<1860::AID-CNCR2820761027>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- 6 Kaplinsky C, Fisch A, Cohen IJ, et al. T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma. Med Pediatr Oncol 1992; 20: 229–231.
- 7 Megonigal MD, Rappaport EF, Jones DH, et al. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Proc Natl Acad Sci 1997; 94: 11583–11588.
- 8 Magrath IT. African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol 1991; 13: 222–246.
- 9 Salloum E, Tallini G, Levy A, et al. Burkitt's lymphoma–leukemia in patients treated for Hodgkin's disease. Cancer Invest 1996; 14: 527–533.
- 10 Ikeda T, Sato K, Yamashita T, et al. Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome. Br J Haematol 2001; 115: 69–71.
- 11 Diller L, Sexsmith E, Gottlieb A, et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 1995; 95: 1606–1611.
